Trinity Biotech files for sale of shares

DIAGNOSTIC test manufacturer Trinity Biotech filed yesterday to periodically sell up to $75 million in Class A ordinary shares and equity warrants.

In a registration statement with the US Securities and Exchange Commission, Trinity Biotech said it would use the proceeds from the offering for general corporate purposes, including debt repayment, capital expenditures, acquisitions and working capital.